Portia Mutevedzi to Anti-HIV Agents
This is a "connection" page, showing publications Portia Mutevedzi has written about Anti-HIV Agents.
Connection Strength
1,224
-
Mortality risk in older people on antiretroviral therapy. Lancet HIV. 2015 Sep; 2(9):e352-3.
Score: 0,265
-
Review: [corrected] The changing face of the HIV epidemic in sub-Saharan Africa. Trop Med Int Health. 2014 Sep; 19(9):1015-28.
Score: 0,246
-
Decreased chronic morbidity but elevated HIV associated cytokine levels in HIV-infected older adults receiving HIV treatment: benefit of enhanced access to care? PLoS One. 2013; 8(10):e77379.
Score: 0,234
-
Association of age with mortality and virological and immunological response to antiretroviral therapy in rural South African adults. PLoS One. 2011; 6(7):e21795.
Score: 0,200
-
Implementation and Operational Research: Risk Charts to Guide Targeted HIV-1 Viral Load Monitoring of ART: Development and Validation in Patients From Resource-Limited Settings. J Acquir Immune Defic Syndr. 2015 Nov 01; 70(3):e110-9.
Score: 0,067
-
Determinants of Weight Evolution Among HIV-Positive Patients Initiating Antiretroviral Treatment in Low-Resource Settings. J Acquir Immune Defic Syndr. 2015 Oct 01; 70(2):146-54.
Score: 0,067
-
Reduction in early mortality on antiretroviral therapy for adults in rural South Africa since change in CD4+ cell count eligibility criteria. J Acquir Immune Defic Syndr. 2014 Jan 01; 65(1):e17-24.
Score: 0,059
-
CD4 count slope and mortality in HIV-infected patients on antiretroviral therapy: multicohort analysis from South Africa. J Acquir Immune Defic Syndr. 2013 May 01; 63(1):34-41.
Score: 0,057
-
Regression discontinuity designs in epidemiology: causal inference without randomized trials. Epidemiology. 2014 Sep; 25(5):729-37.
Score: 0,016
-
Retention in HIV care for individuals not yet eligible for antiretroviral therapy: rural KwaZulu-Natal, South Africa. J Acquir Immune Defic Syndr. 2011 Mar 01; 56(3):e79-86.
Score: 0,012